KROGER Cuts Same-Store Sales Outlook While Keeping EPS Guidance
Kroger reported adjusted EPS of $1.09 on 0.2% identical sales growth and lowered its full-year comparable sales forecast to 0.2%-0.8%.
Kroger reported adjusted EPS of $1.09 on 0.2% identical sales growth and lowered its full-year comparable sales forecast to 0.2%-0.8%.
Tadaa Technology will supply the AI backbone for a 1,000-acre solar farm feeding a data centre under a 25-year power arrangement, targeting $7.3M in annual revenue.
Alpha Compute has signed definitive agreements for Utica and Marcellus acreage with more than 75 wells, and plans to build a data center on the site.
Palisade Bio can start the Phase 2 ASCENTRA-CD trial of its oral PDE4 prodrug, with first dosing targeted for Q1 2027 and a primary readout in Q1 2028.
VERSATILE-002 results for PDS0101 plus pembrolizumab show 39.3 months median overall survival in checkpoint-inhibitor-naive HPV16-positive head and neck cancer.